TCRT
Price:
$4.99
Market Cap:
$9.87M
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers; hunTR, a human neoantigen T-cell receptor platform; and mbIL-15 to treat solid tumors. Alaunos Therapeutics, Inc. has a license agreement with PGEN Therapeutics, Inc.; research and development agreement with The University of Texas MD Anderson Cancer Center; and a patent license agreement, and research and developm...[Read more]
Industry
Biotechnology
IPO Date
2005-08-24
Stock Exchange
NASDAQ
Ticker
TCRT
According to Alaunos Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -169.34%. This represents a change of 224.57% compared to the average of -52.17% of the last 4 quarters.
The mean historical ROE of Alaunos Therapeutics, Inc. over the last ten years is -119.43%. The current -169.34% ROE has changed 41.79% with respect to the historical average. Over the past ten years (40 quarters), TCRT's ROE was at its highest in in the June 2016 quarter at 252.36%. The ROE was at its lowest in in the September 2018 quarter at -313.45%.
Average
-119.43%
Median
-114.98%
Minimum
-557.16%
Maximum
213.84%
Discovering the peaks and valleys of Alaunos Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 471.36%
Maximum Annual ROE = 213.84%
Minimum Annual Increase = -255.58%
Minimum Annual ROE = -557.16%
Year | ROE | Change |
---|---|---|
2024 | -226.81% | -59.29% |
2023 | -557.16% | 471.36% |
2022 | -97.52% | -26.37% |
2021 | -132.45% | 108.26% |
2020 | -63.60% | -66.04% |
2019 | -187.26% | 201.65% |
2018 | -62.08% | -210.63% |
2017 | 56.12% | -73.76% |
2016 | 213.84% | -255.58% |
2015 | -137.45% | 46.36% |
The current ROE of Alaunos Therapeutics, Inc. (TCRT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-293.83%
5-year avg
-215.50%
10-year avg
-119.43%
Alaunos Therapeutics, Inc.’s ROE is greater than Precigen, Inc. (-509.44%), less than CorMedix Inc. (22.57%), greater than Sangamo Therapeutics, Inc. (-351.16%), less than Comera Life Sciences Holdings, Inc. (172.01%), less than Quoin Pharmaceuticals, Ltd. (-0.45%), greater than Senti Biosciences, Inc. (-177.25%), greater than Kiora Pharmaceuticals, Inc. (-42.81%),
Company | ROE | Market cap |
---|---|---|
-509.44% | $540.18M | |
22.57% | $835.10M | |
-351.16% | $120.74M | |
172.01% | $6.15K | |
-0.45% | $5.23M | |
-177.25% | $55.55M | |
-42.81% | $9.13M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alaunos Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alaunos Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Alaunos Therapeutics, Inc.'s ROE?
How is the ROE calculated for Alaunos Therapeutics, Inc. (TCRT)?
What is the highest ROE for Alaunos Therapeutics, Inc. (TCRT)?
What is the 3-year average ROE for Alaunos Therapeutics, Inc. (TCRT)?
What is the 5-year average ROE for Alaunos Therapeutics, Inc. (TCRT)?
How does the current ROE for Alaunos Therapeutics, Inc. (TCRT) compare to its historical average?